Govt Job: For M.Pharm, M.Sc, M.Tech in Dept of Science and Technology

Kalinga Institute of Industrial Technology, formerly KIIT University, is a private deemed university located in Bhubaneswar, Odisha, India.

It primarily emphasizes on higher education and research in engineering and science.

It offers:

  • 34 Undergraduate,
  • 32 Postgraduate,
  • 10 Integrated,
  • 11 Ph.D and
  • 7 Postdoctoral research programmes in the fields of Science and Engineering, Medical Science, Management, Law, Film and Media, Humanities and Yoga and sports.

The admissions for B.Tech. programmes are purely based on merit as per the results in KIITEE exam.

Post : Junior Research Fellow

Applications are invited from eligible candidates for the Junior Research Fellow (JRF) to work on the project “Vitamin biofortification through fermentation of common energy-dense foods in India and South Africa for young children 3-10 years” sponsored by the Department of Science and Technology (DST), Government of India.

The required Qualifications : Candidates should have passed their M.Sc./M.Tech./M.Pharm. or equivalent qualification in Life Sciences or allied subjects (Biochemistry/ Biotechnology / Molecular Biology/ Microbiology etc) with a minimum of 60 % marks (or equivalent grade point).

NET/GATE qualified candidates will be preferred.

The duration of the fellowship will be for 2 years 2 months, subject to the availability of the fund.

Fellowship : Rs 31,000 per month + HRA

Age Limit :The upper age limit of the candidate should be below 28 years as on 01-10- 2021. Age relaxations will be given as per the Government of India rules.

Interested candidates may send their application in plain paper along with complete bio-data (with details of qualifications i.e., examination passed, year, division and percentage of marks from 10th board onwards, the address of communication, c-mail and phone/mobile number) to Dr. Sandeep Kumar Panda, Assistant Professor, School of Biotechnology, KMT Deemed to be University, Campus 11, Patia, Bhubaneswar – 751024.

A soft copy of the application can be mailed to sandeep.panda@kiitbiotech.ac.in.

The last date for the submission of the application is 10th June, 2022.

Only short-listed candidates will be called for an interview.

Note : Virtual or Physical mode interview will be conducted depending on COVID- 19 situation.

• No TA/DA will be paid to the candidates to appear for the interview.

• Original documents should be produced at the time of the interview.

Related Posts

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

The inspection revealed incomplete manufacturing records, poor hygiene, inadequate quality-control systems and the omission of ingredients specified in approved Ayurvedic formulations. The Maharashtra Food and Drug Administration (FDA) on Thursday…

Amneal Pharma completes acquisition of Kashiv BioSciences

Amneal Pharmaceuticals, Inc. announced the completion of its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars leader with end-to-end capabilities across research, development, manufacturing and commercialization. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Amneal Pharma completes acquisition of Kashiv BioSciences

Amneal Pharma completes acquisition of Kashiv BioSciences

Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis